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Abstract
The Beighton Score (BS) is a set of manoeuvres in a nine-point scoring system, used as the standard method of assessment 
for Generalised Joint Hypermobility (GJH). It was originally developed as an epidemiological tool used in screening large 
populations for GJH, but later adopted as a clinical tool for diagnostic purposes. Its ability to truly reflect GJH remains con-
troversial, as joints within the scoring system are predominantly of the upper limb and disregard many of the major joints, 
preventing a direct identification of GJH. Furthermore, a consistent finding in the literature whereby the BS failed to identify 
hypermobility in joints outside the scoring system suggests its use as an indirect indicator of GJH is also not viable. As such, 
the collective findings of this review demonstrate a need for a change in clinical thinking. The BS should not be used as the 
principle tool to differentiate between localised and generalised hypermobility, nor used alone to exclude the presence of 
GJH. Greater emphasis should be placed on a clinician’s judgement to identify or exclude GJH, according to its full definition.
Keywords Beighton score · Generalised joint hypermobility · Joint hypermobility · Joint hypermobility syndrome · Ehlers–
Danlos Syndrome · Range of motion · articular
Introduction
Joint Hypermobility (JH) is not a diagnosis, but a descrip-
tor, used to define a joint that exceeds its normal Range of 
Motion (ROM), taking into account age, sex and race [1, 2]. 
This feature is predominantly determined by the tightness or 
laxity of ligaments, which in turn, is influenced by genetics, 
involving the connective tissue genes collagen, elastin, and 
fibrillin [2]. As a consequence, Heritable Connective Tis-
sue Disorders (HCTD) like the Ehlers–Danlos Syndromes 
(EDS), Marfan Syndrome, and Osteogenesis Imperfecta, 
result in systemic ligamentous laxity and can present with 
Generalised Joint Hypermobility (GJH). The diagnosed 
prevalence of the conditions EDS and Joint Hypermobility 
Syndrome (JHS), which are associated with GJH, has been 
found to be 1 in 500 [3], although GJH is also present in the 
general healthy population. GJH is also a descriptor, and is 
defined as the simultaneous presence of JH at the four limbs 
and axial skeleton, with involvement of both the major and 
minor joints [1].
The BS has been used as the standard method of assess-
ment of GJH in research studies, as well as in all present 
and previous diagnostic criteria for the hypermobility syn-
dromes. The BS has its origins in 1964 when Carter and 
Wilkinson devised a scoring system to define GJH to investi-
gate its association with congenital hip dislocation [4]. GJH 
was considered positive if the individual scored 3 or more 
from five criteria, requiring both upper and lower limbs to be 
involved from the following: apposition of the thumb to the 
forearm, dorsiflexion of the ankle, as well as hyperextension 
of the elbows, knees, and all the metacarpophalangeal joints 
(MCPJs). This method was later modified by Beighton et al. 
to determine the epidemiology of GJH in an African popula-
tion [5]. Hyperextension of all the MCPJs was replaced with 
just the little finger beyond 90°, and dorsiflexion of the ankle 
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was replaced with forward flexion of the trunk, creating the 
BS out of a total of 9 which is widely used today.
Alternative scoring systems to the BS exist. This includes 
the Rotès–Quérol scoring system, which includes additional 
measurements of the cervical and lumbar spine, shoulder, 
hip, and metatarsophalangeal joints (MTPJs) to give a total 
score of 11 [6]. The Hospital Del Mar criteria have a score 
of 10, and include the thumb, MCPJs, MTPJs, elbows, 
shoulders, hip, knee, patella, ankle/feet, and an assessment 
for ecchymoses or easy bruising [6]. Since both these scor-
ing systems are more time consuming in nature, they have 
consequently seen limited use in practice, while the BS has 
become the standard method of assessment.
Since its creation in 1973, the BS has remained 
unchanged, and adopted both for research purposes and as 
a clinical diagnostic tool. However, it was originally devel-
oped as an epidemiological tool, involved in screening large 
populations for GJH. Neither Carter and Wilkinson [4] nor 
Beighton et al. [5] provide any evidence-based justification 
for the selection of joints within the assessment method. It 
appears joints were not specifically selected to accurately 
reflect GJH or hypermobility present in other joints, but 
chosen instead on a functional basis, for ease of access and 
efficiency without the need for equipment. As a result, two 
thirds of the joints being assessed are located in the upper 
limbs and many of the major joints are disregarded, and with 
only a single plane of joint motion measured. In addition, 
the method is an ‘all or nothing’ system, only determin-
ing the presence of hypermobility and giving no indication 
of its severity. There is no clear description or guidance in 
the original text for how the test should be performed, or 
whether the active or passive ROM for some of the joints 
should be measured. While GJH is generally indicated by 
a score of ≥ 4/9 in adults, we can find no evidence-based 
justification for use of this cut-off value. Its ability to truly 
reflect GJH is, therefore, questionable and this is concerning. 
From a nosologic perspective, it could lead to the incorrect 
classification of disease, which in turn has implications for 
research. There are potential consequences for the develop-
ment of valid molecular diagnostic techniques, as well as 
effective treatment and management strategies for patients. 
There are further concerns for its use in clinical practice 
and the socioeconomic impact this may have. Unrecognised 
hypermobility disorders may lead to patients being denied 
access to the appropriate healthcare services, as well as the 
necessary disability support needed to enable employment, 
increase economic output and lead a fulfilling social and 
family life. Indeed, this is a difficulty already described by 
those with a diagnosis of EDS [7]. The continued use of 
the BS as a clinical diagnostic tool, particularly within the 
2017 International Classification of EDS for the diagnosis 
of hypermobile EDS (hEDS) [8], therefore, remains con-
troversial since it was originally intended as a screening 
tool. Despite this, no thorough examination or review of its 
clinical properties has yet been performed. The aim of this 
paper is to review the validity and reliability of the BS as an 
assessment method to classify GJH, and further discuss its 
suitability for diagnostic purposes.
 Methods
A narrative literature search formed the basis of this review. 
A formal meta-analysis was not attempted due to substantial 
heterogeneity in study methodology, GJH classifications and 
BS cut-off points. Instead, the aim of the literature search 
was to identify and present all relevant studies assessing the 
clinical aspects of the BS to enable a discussion regarding 
its use as a diagnostic tool, and more specifically, its ability 
to exclude the presence of GJH.
The electronic databases of PubMed and Scopus were 
chosen and a Boolean search strategy was employed to 
identify relevant articles published in the English language 
before Oct 2020. Studies were initially identified through use 
of the search term “Beighton Score”, alongside “validity”, 
“correlation”, or “reliability”. The search was expanded for 
validity by including various joints as search terms, such 
as “shoulder”, “temporomandibular joint”, “ankle”, etc., 
and further papers were identified through a snowballing 
approach.
Eligibility criteria for validity included specific study 
design and participant demographic. Studies were required 
to examine a statistical association between the BS and a 
measurement of hypermobility in other joint(s) in partici-
pants reflective of a representative population. Studies in 
which participants were exclusively from hypermobile 
skewed populations such as children and gymnasts were 
excluded, unless findings were of significant relevance to 
the discussion of the research topic.
Validity of the Beighton Score
There is no gold standard test for classifying GJH in an indi-
vidual. However, the BS itself is now often considered and 
used as such, though as stated, this was not its original pur-
pose. Neither Carter and Wilkinson [4] nor Beighton et al. 
[5] devised the BS for diagnostic purposes, and as such, 
it does not appear to have been validated by examining its 
association with other hypermobile joints and its ability to 
truly detect widespread GJH in adults.
The BS has, however, been validated in children [9]. 
Here, in 500 children aged 6–12 years, 16 ROMs in eight 
different joints were measured using the extended stand-
ardised joint mobility protocol and compared with the 
BS. Those children classed as hypermobile (BS ≥ 5) were 
Rheumatology International 
1 3
found to have a significantly increased ROM in all other 
joints measured, including the ankle, hips, and shoulders, 
as well as an association with other features indicative of 
a hypermobility syndrome, like pes planus [9]. This study 
demonstrates that the BS is a valid method for determin-
ing GJH in children. However, hypermobility is known to 
be highly prevalent in children and also diminishes with 
age [5, 10]. As such, children with a positive BS are more 
likely to present with hypermobile joints outside the BS, 
and so the same inferences on its validity cannot be made 
with regards to its use in adults. Though no study has 
directly validated the BS for GJH in adults, this can be 
inferred by examining its association with hypermobility 
present in other singular joints.
It has been demonstrated that the BS does not correlate 
with hypermobility of the shoulders [11, 12]. In one study, 
the BS and various measures of shoulder laxity were taken 
from 160 individuals aged 16–35 years, and no correlation 
was found between the measurements, with a positive BS 
(≥ 4) showing low sensitivity and low positive predictive 
values for shoulder laxity [12]. Even when the BS cut-off 
value was raised to ≥ 6, there was no significant increase in 
the positive predictive value [12]. In addition, the BS may 
not necessarily reflect joint instability, as demonstrated in 
another study which found no relationship between a BS 
of ≥ 6 and instability of the shoulder [13]. The shoulder is of 
particular clinical relevance as it is often reported by hEDS 
patients to be the most troublesome [14] and most prone 
to dislocation [15, 16]. Some have suggested that shoulder 
dislocation may even be the first presenting sign of hEDS 
[17]. Indeed, in a study of over 100 patients with a strong 
suspicion of EDS based on a presentation of symptoms, fam-
ily history and other physical findings, 45 had a negative BS 
(BS < 4). However, their mean glenohumeral abduction was 
still 20° higher than normal, highlighting the significance of 
shoulder hypermobility, even in potential patients who may 
have a negative BS [18].
A lack of correlation has also been found between the BS 
and laxity of the joints in the lower limb. In one study, the 
BS and instrumented measurements of knee and ankle laxity 
were taken from over 50 individuals with a mean age of 21, 
and a positive BS (≥ 4) showed non-significant correlations 
with those measurements, with the authors concluding that 
both knee and ankle laxity are joint specific and not gener-
alisable [19]. Another in over 140 children aged between 13 
and 15 years found no correlation between the BS and ankle 
dorsiflexion [20]. However, some studies contradict these 
findings. A smaller study in over 30 adults found a weak 
but significant association between the BS and instrumented 
measurement of knee laxity as well as knee instability [21], 
while another found those with a BS ≥ 6 had a statistically 
significantly higher ankle dorsiflexion range by 4° [22], 
though this value may not be clinically significant.
The BS has been found to correlate with spinal mobility 
[23, 24]. In a study of over 60 individuals, those with a BS 
of ≥ 4 demonstrated significantly increased spinal interver-
tebral mobility, though this was assessed through functional 
radiographs and not through physical manoeuvres [24]. 
The manoeuvre presumed to measure spinal hypermobility 
within the BS is the forward flexion of the trunk manoeuvre. 
However, this does not appear to truly reflect inherent hyper-
mobility of the spine or axial skeleton, as the manoeuvre 
is known to be trainable, as demonstrated by ballet danc-
ers [25], and is also known to be affected by hamstring 
length [26]. A study in men found shorter hamstring lengths 
to be associated with a decreased ROM of both the pelvic 
and lumbar angle, restricting the forward flexion manoeuvre 
[26]. Of clinical significance is the contribution of muscle 
retractions on this movement, particularly in hypermobile 
patients. In one study of over 200 hypermobile patients 
(BS ≥ 5) aged 2–70 years, 87.5% were found to have mus-
cle retractions which prevented them from performing the 
manoeuvre [27]. From this study, the authors demonstrated 
that 84.2% of hypermobile patients, presenting with a cur-
rent BS of ≥ 5, were unable to perform the forward flexion 
manoeuvre which would give them one further point on the 
BS [27]. It is possible, therefore, that many people scoring 
below the current diagnostic cut-off values may be deprived 
of a diagnosis due to the presence of such muscle retractions, 
again raising concerns regarding the validity of the BS for 
diagnostic purposes.
The same finding has also been noted in hypermobile 
children, even before age-related loss of hypermobility is 
expected. In a study of over 400 children between 6 and 
11  years of age, 86% of those who were hypermobile 
(BS ≥ 5) could not perform the manoeuvre [28], while 
another in over 200 children aged 10–13 years, found 84% 
of hypermobile males (BS ≥ 4) and 78% of hypermobile 
females (BS ≥ 5) could not perform the forward flexion 
manoeuvre [29]. When compared with children without 
GJH, no differences were found between the groups in their 
abilities, and further lack of differences was found in the 
flexibility of the trunk and the muscle–hip complex [29]. It is 
thought that hypermobility leads to alterations in the activa-
tion of the pelvic and lower limb musculature to compensate 
for joint instability [30], restricting lumbar movement and 
preventing forward flexion. It has been suggested that the 
presence of muscle retractions and an inability to perform 
the manoeuvre may actually be indicative of hypermobility 
[27]. One study has concluded that while this manoeuvre has 
high specificity (93.7%), its sensitivity is so low (13.8%) that 
it adds no additional value to the BS [28]. These findings, in 
which the vast majority of confirmed patients are unable to 
perform the very manoeuvre contributing to their diagnosis, 




Another joint of particular clinical relevance is the Tem-
poromandibular Joint (TMJ), and it is becoming increasingly 
recognised that there is a relationship between both GJH and 
hEDS, and TMJ Disorders (TMD) [31]. TMD is character-
ised by a symptomatic presentation of pain or discomfort 
associated with the TMJ, with a decreased functionality in 
opening and chewing motions. Most studies examining this 
relationship have found the prevalence of GJH to be higher 
in the TMD population than normal controls [31]. However, 
this relationship has not necessarily translated into direct 
correlations between GJH (BS ≥ 4) and hypermobility of the 
TMJ itself. A study in 60 TMD patients found no significant 
correlation between a positive BS and TMJ hypermobility 
as measured by lateral X-rays [32], while another in over 
40 female volunteers found that the range of mandibular 
motion did not significantly differ between those with a posi-
tive and negative BS [33]. This is further supported by two 
studies in over 60 female TMD patients, where the BS did 
not correlate with MRI-evident displacement of the TMJ 
[34, 35]. However, a conflicting study found a significant 
positive correlation between mandibular ROM and a positive 
BS in a study of over 30 women with TMD [36]. Another 
found a weak but significant positive association in over 200 
15–16-year-old hypermobile girls [37]. It is plausible that 
those with GJH may initially present with TMJ hypermobil-
ity, but repeated trauma including subluxations and disloca-
tions facilitates the development of TMD, resulting in lim-
ited mobility of the TMJ itself. These studies demonstrate 
that in those who develop a symptomatic presentation, joint 
ROM itself may not always be the most reliable indicator of 
inherent ligamentous laxity.
The BS appears to correlate better with joints of the upper 
limbs, including the thumb and wrist. A study in over 160 
individuals found that the BS correlated moderately and sig-
nificantly with laxity of the thumb when measured via stress 
view radiograph [38], while a study in 50 women found a 
low but significant correlation between BS and assessments 
of wrist laxity [39].
Reliability of the Beighton Score
The reliability of the BS simply refers to its ability to pro-
duce consistent results. More specifically, intra- and inter-
examiner reliability refers to the same or different examiners, 
respectively, in their ability to interpret and allocate the same 
BS to the same individual. This is of note, as the BS is an 
“all or nothing” system. It does not measure the degree of 
hypermobility in each joint, only assigning a positive score 
if the joint ROM passes the required threshold. Therefore, 
joints presenting with borderline hypermobility are left open 
to interpretation on its scoring by different examiners or on 
different occasions.
This is particularly relevant as various circumstantial 
factors may promote or diminish inherent joint ROM, and 
influence the overall BS. For example, various studies have 
shown that hypermobility is diminished on the dominant 
side of the body [5, 40, 41]. Stretching and warming up 
have been shown to increase joint ROM [42]; while tem-
perature, both heat and cold, have been shown to affect the 
flexibility of tendons and ligaments, ultimately influencing 
joint ROM [43, 44]. In addition, hormonal fluctuations dur-
ing the menstrual cycle are thought to affect laxity of the 
knees [45]. Together, it is conceivable that an individual’s 
BS could be dependent on circumstantial factors at the time 
of examination, such as climate, temperature, stage of men-
strual cycle, and prior physical activity, particularly in those 
with a borderline presentation. In addition, there is no agreed 
consensus on how the test should be performed or inter-
preted. For example, whether the passive or active ROM of 
the joints should be measured, whether historical hypermo-
bility should also be considered, or whether any allowances 
for exceptions such as injuries, surgery, or even pregnancy 
should be made. These factors could further impact its reli-
ability when performed by different examiners or on differ-
ent occasions. Therefore, the ability of the BS to consist-
ently and reliably assign an individual with GJH is relevant, 
particularly for clinical applications.
Reliability has been examined in various studies at the 
level of both individual manoeuvres within the BS, for 
example, agreement on assigning a positive score for a par-
ticular joint, but also the overall score and classification of 
GJH, for example, agreement on classifying an individual 
with a BS of 5, and therefore with GJH. The kappa statis-
tic is the most often used correlation statistic used to ana-
lyse reliability, which calculates the percentage agreement 
between two scores while also taking into account chance 
agreement, i.e. the possibility that examiners may correctly 
guess the scoring in the event of uncertainty rather than 
providing a genuine interpretation, and thereby providing a 
more accurate representation of reliability [46]. The kappa 
statistic ranges from − 1.0 to + 1.0, with negative values indi-
cating disagreement, zero indicating no agreement, and a 
value of 1.0 indicating perfect agreement. Generally, most 
reliability studies have consistently produced kappa values 
between 0.4 and 0.8, indicating the BS to demonstrate mod-
erate intra- and inter-examiner reliability in both adults and 
children (Table 1) [6, 47–52].
However, as a research and clinical diagnostic tool, 
moderate reliability may not be sufficient. Kappa values 
below 0.6 have been suggested to be inadequate and, there-
fore, potentially not appropriate in a health care or clini-
cal research setting [46], yet this is a value which is not 
consistently met in the aforementioned studies (Table 1). 
In addition, a recent systematic review performed a best-
evidence synthesis for the reliability of the BS, using the 
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Consensus-based Standards for selection of health Meas-
urement Instrument (COSMIN) checklist [53]. This check-
list evaluates the methodological quality of the reliability 
studies included in the systematic review, which are then 
analysed alongside the results of the actual studies, while 
taking into account the number of studies included and 
the total sample size. From the 5 criteria—strong, moder-
ate, limited, conflicting, and unknown—the review rated 
the overall strength of evidence to support the reliability 
of a positive BS to be limited to conflicting [53]. While 
this was the best performing GJH assessment method from 
those included, the review still demonstrated that there is 
not sufficient evidence to entirely support the use of the BS 
as a diagnostic tool. While the BS has not demonstrated 
poor reliability, more research is needed to clarify its suit-
ability for clinical and research purposes. Better stand-
ardisation of the BS with an agreed consensus and clearer 
guidelines produced as to how it should be performed and 
interpreted could improve reliability, particularly for clini-
cal applications.
The Beighton Score cut‑off points: 
the influence of age, sex and race
The original study by Beighton et al. appears to have classi-
fied GJH arbitrarily, requiring a BS cut-off of ≥ 4 [5], which 
is the definition generally used in most studies. Adjustments 
to the cut-off value, however, are often debated, to take into 
consideration factors that influence GJH such as age, sex, 
and race [9, 10, 54–56]. The influence of these factors have 
been demonstrated in studies examining the prevalence of 
hypermobility within and between these populations, as well 
as their relationship with symptoms.
With regards to racial differences, several studies have 
shown a general trend of Caucasian populations demon-
strating a lower prevalence of GJH [10, 57–59], which is 
Table 1  Intra- and inter-
examiner reliability for positive 
hypermobility findings for 
individual manoeuvres, GJH 
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increased in Asian [59–61], African [59, 62], and Arab [40, 
59] populations. However, it has not yet been established if 
this is associated with a higher prevalence of hypermobility-
related symptoms, with studies demonstrating conflicting 
results. A study in West Africans showed no increase in 
articular symptoms [62]. However, one study with Indian 
schoolchildren participants showed an association between 
higher BS and musculoskeletal pain [63], while another 
study with Iraqi University student participants demon-
strated a significant correlation with both articular symptoms 
and syndromic features [40].
The prevalence of hypermobility has consistently been 
shown to be higher in females across the lifespan [5, 10, 40, 
41, 54, 56–59, 62, 64–68]. These differences become more 
pronounced around the age of 14, with females demonstrat-
ing significantly higher rates of GJH [10, 54, 56], while the 
decrease in hypermobility following adolescence is more 
pronounced in males [69].
Prevalence rates of hypermobility within specific age 
groups are difficult to accurately discern due to sample ages 
and sex varying considerably between and within stud-
ies. However, hypermobility has consistently been shown 
to be highly prevalent in the youngest children and shown 
to decrease with age, falling rapidly throughout childhood 
and then at a slower rate during adulthood [5, 10, 60]. This 
decreasing trend is demonstrated in various studies in chil-
dren and adolescents, with the prevalence of GJH (BS ≥ 4) 
ranging from 64.6% in children aged 4–7 [65], 35.6% at age 
10 [70], 9.4% in those aged 12–13 years [64], and 11.7% in 
children aged 13–19 [68].
While the prevalence of hypermobility is significantly 
higher in younger children, some studies have shown that this 
is not associated with increased musculoskeletal symptoms 
[66, 71], though there is other evidence which contradicts this 
[63]. From over 380 children examined at ages 10–12, those 
with a BS of ≥ 6 were shown to be more likely to suffer mus-
culoskeletal pain at a 4-year follow-up, and that this was an 
independent predictor for pain recurrence [72]. Additionally, 
in children presenting with lower limb pain, those who were 
hypermobile (BS ≥ 6), were also found to have a threefold sig-
nificantly increased risk for lower limb pain recurrence after 
4 years [73]. However, one study has shown that within the 
hypermobile population, symptomatic children can be differ-
entiated from asymptomatic children through other findings 
[74]. These symptomatic children demonstrated significantly 
higher skin extensibility, and the degree of hypermobility 
in each joint was also higher. There was also a significant 
increase in collagen degradation products like hydroxypro-
line in the urine, alongside significantly decreased ultrasound 
measurements in the bone indicating lower bone density, as 
well as a lower diastolic blood pressure [74].
Hypermobility continues to decline throughout adult-
hood, although at a slower rate than is seen in childhood [5, 
10, 60], with the probability of being classified with GJH 
(BS ≥ 4) decreasing 5.5% for every 1 year increase in age 
[10]. In a study of 200 individuals over 70 years of age, no 
one was found to have a BS higher than 2 [10]. The loss of 
hypermobility with age has also been specifically demon-
strated within the hypermobile population, with the deline-
ation of three distinct phases [75–77]. The first decade of 
life, i.e. the “hypermobility” phase, presents with marked 
hypermobility, with joint sprains and strains occurring in 
around 40% of patients. The second “pain” phase occurs in 
the second decade of life and is characterised by widespread 
chronic pain with increased joint instability and decreasing 
hypermobility. Finally, the third “stiffness” phase is char-
acterised by a dramatic decrease in JH with a diminished 
quality of life. A cut-off age of 33 has been established, after 
which most diagnosed hypermobile patients will not reach 
the cut-off of 4 on the BS [76], questioning its suitability in 
the diagnosis of adult patients.
Discussion
Any clinical test or method used for diagnostic purposes 
must be a valid and accurate indicator for disease. For GJH, 
this would be a method that accurately identifies JH at both 
major and minor joints of the four limbs and axial skeleton. 
The efficacy of such methods is formally determined by 
comparisons to the gold standard method through measure-
ments of sensitivity and specificity. However, no official gold 
standard method exists for GJH to allow such measurements 
of the BS. Its sensitivity and specificity, however, can be 
inferred by examining its ability to identify those whose 
hypermobility meets the definition of GJH.
With regards to sensitivity, this is an aspect of the test that 
allows identification of all those with the disease. For this 
to be clinically useful, a negative result should effectively 
exclude the presence of disease. However, this review has 
raised concerns about the ability of the BS to do this. As 
described, the selection of joints within the scoring system 
does not accurately represent the definition of GJH and, 
therefore, cannot be used as a direct indicator of GJH. Nei-
ther can the BS value be used as an indirect indicator of 
GJH, as several studies have demonstrated no association 
of the BS value with hypermobility present in other joints. 
Therefore, a positive BS value is unable to effectively iden-
tify all presentations of GJH and false-negative outcomes 
become feasible. Here, individuals may receive a negative 
BS outcome, yet may still present with JH in locations out-
side the scoring system that fulfil the definition of a GJH. 
The sensitivity of the BS, therefore, is not sufficient to 
exclude GJH in individuals. This also relates to specificity.
Specificity refers to the ability to effectively identify all 
those without the disease. This aspect of the BS would be 
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clinically useful only if a positive result could effectively 
confirm the presence of GJH. However, the selection of 
joints within the BS prevents its use as a direct positive 
indicator of GJH, as this value bears no reflection on the 
location, spread, and type of joints that have been affected 
by hypermobility. Therefore, the possibility of false-positive 
outcomes is also feasible. For example, an individual with 
localised hypermobility limited to the upper limbs could 
potentially generate a BS of up to 6 and an incorrect clas-
sification of GJH, yet this same value can also be reached by 
an individual with a genuine presentation of GJH. Therefore, 
the BS does not appear to be a sufficiently specific tool to 
differentiate between generalised or localised hypermobility 
and enable an effective delineation of GJH. Indeed, the need 
to differentiate between the two is of clinical importance, 
with a generalised presentation indicating the presence of 
systemic ligamentous laxity and, hence, a potential HCTD. 
The inability of the BS to effectively do this is significant 
for its use as a clinical and diagnostic tool.
There is widespread debate in the literature about adjust-
ing the BS cut-off value to improve these aspects of the BS, 
with a particular emphasis on specificity and preventing 
overdiagnoses in those from more hypermobile populations 
[9, 10, 54, 56]. Indeed, the consensus of several researchers 
is that GJH should reflect an abnormality in the physiologi-
cal context, and the categorisation of the BS values should, 
therefore, be more comparable to that of a reference range. 
Hence, it is suggested that the cut-off value is adjusted to 
allow identification of only those with a more extreme pres-
entation within that population, i.e. a score that is 2 S.D. 
above the mean, or in the upper 5%, within each age, sex, 
and race category [10, 54, 55]. However, such a recommen-
dation may not be appropriate for several reasons. First, the 
assertion that GJH is a physiological abnormality may not 
be medically accurate in this context. Here, the term ‘physi-
ological abnormality’ is more appropriately applied to the 
joint that exceeds its normal ROM. The term GJH was then 
intended to describe the presentation of this physiologi-
cal abnormality, i.e. JH, as systemic rather than localised, 
something this review has demonstrated may not be suffi-
ciently reflected in the BS value itself, nor facilitated through 
adjustment to its cut-off point. Second, the higher preva-
lence observed in certain populations may not constitute 
instances of overdiagnoses, but may be a genuine finding of 
higher prevalence. For example, the increased prevalence 
of GJH seen in females is also associated with an increased 
symptomatic presentation and, therefore, likely to represent 
increased penetrance of an underlying HCTD [78]. If the 
cut-off value is raised further for specific populations to 
prevent ‘overdiagnosis’, those presenting with genuine GJH 
may be prevented from an accurate diagnosis without the 
additional hypermobile joints needed to meet the raised cut-
off. Ethical concerns then also arise, if it appears a diagnosis 
is restricted to meet a specific prevalence rate, rather than 
reflecting the physiological presentation of a condition.
Additional joints could be included in the BS and a new 
cut-off point established to better aid a valid identification 
of GJH. Indeed, making use of the existing Hospital Del 
Mar or Rotès–Quérol scoring systems, which are effectively 
extensions of the BS could also be considered [6]. The valid-
ity and reliability of these scoring systems are difficult to 
determine since published findings into these aspects are 
scarce [6, 47, 48]. However, since such scoring systems bet-
ter reflect the definition of GJH, they may be more suitable 
for diagnostics than the BS. Fundamentally, however, they 
still present with the same limitation. They do not directly 
measure the systemic nature of an individuals’ JH, and only 
count the number of select hypermobile joints an individual 
presents with.
Further suggestions to adjust the BS cut-off could be 
made for the purposes of better identifying those at risk 
of pathologic sequalae. Indeed, several studies have dem-
onstrated that a higher BS is associated with greater pain 
persistence and recurrence [72, 73]. While this may be 
appropriate for preventative medicine, from a diagnostic 
perspective, it seems unnecessary to use predictive meth-
ods to categorize future symptomatology when a simple 
consultation with the patient can directly confirm the pres-
ence of symptoms. Consequently, raising the cut-off for this 
purpose or any of the aforementioned reasons would further 
diminish the sensitivity of the BS. This increases the risk of 
generating false negatives, and further excludes those with 
borderline GJH but a true systemic HCTD presentation from 
receiving an accurate diagnosis.
Indeed, this is an issue that has already been demonstrated 
and recently highlighted in a case study of two patients with 
the classical form of EDS (cEDS) [79]. An official diagno-
sis of cEDS is now only confirmed with molecular testing; 
however, cases are suspected and provisional diagnoses made 
based on clinical features, of which one of the major criteria 
is GJH with a BS of ≥ 5 [8]. The case study describes two 
patients, the index case and her mother, who showed subtle 
features of a connective tissue disorder with a suspicion of 
hEDS, yet did not fulfil the 2017 criteria for any form of EDS. 
Both patients scored ‘negatively’ on the BS, with scores of 
3 and 4 out of 9, respectively; however, cEDS was suspected 
due to the characteristic presence of marked skin hyperexten-
sibility in the mother. Subsequent molecular testing revealed 
a COL5A1 splice mutation in both patients confirming a diag-
nosis of cEDS. It is of note, however, that had the diagnosis, 
or indeed the decision to proceed to genetic testing remained 
dependent on the BS, these patients would not have received 
a diagnosis for any form of EDS [79]. This is particularly rel-
evant for cases of hEDS, of which the molecular basis remains 
to be identified, and as such, the potential for misdiagnosis 
greater. It is clear that further research is needed to better 
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understand how JH presents in the various forms of EDS and 
other related HCTDs, and the most effective method with 
which to clinically identify these presentations.
This narrative review has considered a large range of stud-
ies in the literature, which has allowed for a comprehensive 
discussion of the topic. This has highlighted several short-
comings in aspects of the BS’ validity and reliability, which 
has implications for its use as a diagnostic tool. However, the 
limitations of this review should also be recognised. Since 
studies adopt different versions of the BS, and interpreta-
tions of a GJH classification between them, this may have 
influenced their reported outcomes. Furthermore, since a for-
mal meta-analysis was not performed, a formal evaluation of 
study methodology or a risk of bias assessment did not take 
place. As such, this review may have been influenced by stud-
ies of poor quality or ones containing bias. Despite this, the 
review has still demonstrated that insufficient evidence exists 
to justify use of the BS as a method to exclude the presence 
of GJH, or to differentiate GJH from localised hypermobility.
Conclusion
The evidence presented here brings into question the validity 
of the BS as a direct and indirect indicator of GJH, and dis-
putes its continued use as a diagnostic tool. Alternative assess-
ment methods and tools exist, however, with over 300 joints in 
the body, it is unlikely any single assessment method will ever 
truly capture all variable presentations of GJH. Consequently, 
this has highlighted the desperate need for a clinically signifi-
cant diagnostic marker(s) for the hypermobility disorders that 
would render such assessment methods redundant. Until such 
a time comes, use of the BS as a diagnostic tool should be 
one used with caution. Indeed, this review has demonstrated 
that a change in clinical thinking is required. In particular, 
the current use of a negative BS to exclude the presence of 
GJH is a practice that must be discontinued. Ultimately, this 
is not only diagnostically inaccurate, but could also deny a 
patient their fundamental right to a correct diagnosis, and 
hence access to appropriate support. Instead, the BS should 
be used as intended, i.e. as an initial screening method, after 
which other notable joints, for example, the shoulder, hips, 
ankles and remaining digits, could be examined until the clini-
cian is satisfied that no evidence of systemic JH conclusively 
exists, nor any associated syndromic features, before exclud-
ing HCTDs as a diagnosis. Greater emphasis should now be 
placed on a clinician’s judgement to identify or exclude GJH 
according to its definition: the presence of JH at both the 
major and minor joints of the four limbs and axial skeleton.
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